Agilent Technologies (NYSE:A) Price Target Raised to $180.00

Agilent Technologies (NYSE:A) had its target price hoisted by Stifel Nicolaus from $170.00 to $180.00 in a report released on Thursday,Benzinga reports. The firm currently has a buy rating on the medical research company’s stock.

Other equities research analysts have also recently issued reports about the stock. TD Cowen upped their price objective on shares of Agilent Technologies from $155.00 to $180.00 and gave the stock a “buy” rating in a report on Thursday. Royal Bank Of Canada boosted their price target on Agilent Technologies from $155.00 to $185.00 and gave the stock an “outperform” rating in a research report on Thursday. Robert W. Baird upped their price target on Agilent Technologies from $155.00 to $156.00 and gave the stock an “outperform” rating in a research note on Tuesday, May 26th. Jefferies Financial Group started coverage on Agilent Technologies in a report on Thursday, July 9th. They set a “hold” rating and a $135.00 price objective on the stock. Finally, Morgan Stanley raised their price objective on Agilent Technologies from $160.00 to $175.00 and gave the company an “overweight” rating in a research note on Wednesday, August 12th. One investment analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and four have issued a Hold rating to the company. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $170.33.

Agilent Technologies Price Performance

NYSE A opened at $154.47 on Thursday. The company has a quick ratio of 1.62, a current ratio of 2.05 and a debt-to-equity ratio of 0.50. The stock has a market capitalization of $43.63 billion, a PE ratio of 30.41, a price-to-earnings-growth ratio of 2.65 and a beta of 1.25. The company has a 50 day moving average price of $140.30 and a two-hundred day moving average price of $127.04. Agilent Technologies has a 12-month low of $108.35 and a 12-month high of $163.75.

Agilent Technologies (NYSE:A) last announced its quarterly earnings results on Wednesday, August 26th. The medical research company reported $1.62 EPS for the quarter, topping the consensus estimate of $1.49 by $0.13. The company had revenue of $1.88 billion for the quarter, compared to analyst estimates of $1.84 billion. Agilent Technologies had a net margin of 19.53% and a return on equity of 24.45%. Agilent Technologies’s quarterly revenue was up 8.1% on a year-over-year basis. During the same quarter in the prior year, the business posted $1.37 EPS. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. As a group, equities analysts predict that Agilent Technologies will post 6.2 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of the company. Core Wealth Advisors LLC acquired a new stake in shares of Agilent Technologies in the fourth quarter valued at about $26,000. SHP Wealth Management acquired a new position in shares of Agilent Technologies during the 4th quarter worth about $26,000. Navalign LLC acquired a new position in shares of Agilent Technologies during the 4th quarter worth about $27,000. Cedar Mountain Advisors LLC bought a new stake in Agilent Technologies during the 1st quarter valued at approximately $27,000. Finally, Markowski Investments acquired a new stake in Agilent Technologies in the 2nd quarter valued at approximately $27,000.

Key Agilent Technologies News

Here are the key news stories impacting Agilent Technologies this week:

• Positive Sentiment: Agilent reported fiscal Q3 earnings of $1.62 per share, above the $1.48-$1.49 analyst consensus, while revenue of approximately $1.88 billion also exceeded expectations. EPS increased from $1.37 a year earlier, supporting the view that profitability is improving. Agilent Technologies Q3 Earnings and Revenues Top Estimates
• Positive Sentiment: Management raised its full-year guidance following the strong quarter. Commentary highlighted product momentum, a recovery in China, improving demand and expanding margins, all of which could support additional earnings growth. Agilent Technologies Lifts Outlook After Strong Quarter
• Positive Sentiment: Several major firms raised their price targets and maintained bullish ratings after the results. Targets now range from $175 to $190, with upgrades from JPMorgan, Citi, Barclays, Goldman Sachs, Bank of America, Stifel, TD Cowen, Bernstein and RBC. Analysts Raise Agilent Technologies Price Targets
• Neutral Sentiment: Despite the improved outlook, valuation remains relatively demanding: Agilent trades at roughly 30 times earnings, with a PEG ratio above 2.7. This leaves the stock sensitive to any slowdown in demand or disappointment in future guidance.

Agilent Technologies Company Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.